128 related articles for article (PubMed ID: 8447850)
1. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
Guiol C; Ledoussal C; Surgé JM
Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
Furuhama K; Akahane K; Tawara K; Takayama S
Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
[TBL] [Abstract][Full Text] [Related]
3. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
[TBL] [Abstract][Full Text] [Related]
4. Fluoronaphthyridines as antibacterial agents. 6. Synthesis and structure-activity relationships of new chiral 7-(1-, 3-, 4-, and 6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)naphthyridine analogues of 7-[(1R,4R)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihy dro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Influence of the configuration on blood pressure in dogs. A quinolone-class effect.
Remuzon P; Bouzard D; Guiol C; Jacquet JP
J Med Chem; 1992 Jul; 35(15):2898-909. PubMed ID: 1322990
[TBL] [Abstract][Full Text] [Related]
5. Assessment of temafloxacin neurotoxicity in rodents.
Giardina WJ
Am J Med; 1991 Dec; 91(6A):42S-44S. PubMed ID: 1662895
[TBL] [Abstract][Full Text] [Related]
6. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
[TBL] [Abstract][Full Text] [Related]
7. Central effects of endogenous and exogenous GABA.
Czajka R
Acta Physiol Pol; 1978; 29(3):193-205. PubMed ID: 707139
[TBL] [Abstract][Full Text] [Related]
8. Behavioral characterization of the new potent nonselective dopamine agonist pergolide.
Helton DR; Modlin DL; Williams PD
Arzneimittelforschung; 1992 Jul; 42(7):885-90. PubMed ID: 1418051
[TBL] [Abstract][Full Text] [Related]
9. Preliminary pharmacological evaluation of chelidonine in rodents.
Jagiełło-Wójtowicz E; Jusiak L; Szponar J; Kleinrok Z
Pol J Pharmacol Pharm; 1989; 41(2):125-31. PubMed ID: 2594578
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on central nervous and sensory systems and other functions.
Yamamoto S; Takemori E; Hasegawa Y; Nakao K; Inukai T; Nomura M; Morino K; Tsuchiyama M; Hasegawa K; Ikeda H
Arzneimittelforschung; 1991 Jun; 41(6):602-7. PubMed ID: 1930347
[TBL] [Abstract][Full Text] [Related]
11. Adverse reactions and interactions of fluoroquinolones.
Ball P
Clin Invest Med; 1989 Feb; 12(1):28-34. PubMed ID: 2646053
[TBL] [Abstract][Full Text] [Related]
12. Neuropharmacological actions of labetalol.
Dadhich AP; Khanna NK; Vyas DS; Jain P
Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
[TBL] [Abstract][Full Text] [Related]
13. Central action of normetanephrine effect on the behavior of rats.
Kruszewska A
Acta Physiol Pol; 1975; 26(6):583-90. PubMed ID: 1108596
[No Abstract] [Full Text] [Related]
14. Preliminary pharmacological investigation on 38 aminophosphonic acids and their derivatives.
Kleinrok Z; Kolasa K; Chodkowska A; Mastalerz P; Kafarski P
Pol J Pharmacol Pharm; 1985; 37(5):575-84. PubMed ID: 3008130
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies on the central action of novel benzylidene-imidazothiazolone derivatives.
Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Kieć-Kononowicz K; Zejc A
Pol J Pharmacol Pharm; 1989; 41(4):377-83. PubMed ID: 2576811
[TBL] [Abstract][Full Text] [Related]
16. Enhanced entry of ciprofloxacin into the rat central nervous system induced by fenbufen.
Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
J Pharmacol Exp Ther; 1991 Sep; 258(3):1033-7. PubMed ID: 1890610
[TBL] [Abstract][Full Text] [Related]
17. [Effect of aziprine on the central nervous system].
Ponomareva AG
Farmakol Toksikol; 1969; 32(4):403-6. PubMed ID: 5357457
[No Abstract] [Full Text] [Related]
18. [A neuropharmacological study of isoteolin (IST)].
Markov M; Zheliazkov D
Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
[TBL] [Abstract][Full Text] [Related]
19. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.
Saito T; Fukuda T; Sukamoto T; Yoshidomi M; Morimoto Y; Shimohara K; Ito K
Arzneimittelforschung; 1988 Jan; 38(1):66-9. PubMed ID: 2896509
[TBL] [Abstract][Full Text] [Related]
20. On the central antiserotonin action of trazodone.
Baran L; Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
